| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tandem Mass Spectrometry | 8 | 2022 | 288 | 2.640 |
Why?
|
| Lipid Metabolism, Inborn Errors | 3 | 2025 | 30 | 1.150 |
Why?
|
| Creatine | 3 | 2022 | 35 | 1.120 |
Why?
|
| Urinalysis | 3 | 2018 | 73 | 1.040 |
Why?
|
| Mitochondrial Diseases | 3 | 2025 | 152 | 1.010 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2016 | 319 | 0.980 |
Why?
|
| Ophthalmoplegia, Chronic Progressive External | 1 | 2025 | 8 | 0.930 |
Why?
|
| Kearns-Sayre Syndrome | 1 | 2025 | 9 | 0.930 |
Why?
|
| Guanidinoacetate N-Methyltransferase | 3 | 2022 | 8 | 0.900 |
Why?
|
| DNA, Mitochondrial | 1 | 2025 | 230 | 0.830 |
Why?
|
| Chromatography, Liquid | 4 | 2022 | 233 | 0.820 |
Why?
|
| Dihydropyrimidine Dehydrogenase Deficiency | 1 | 2022 | 1 | 0.720 |
Why?
|
| Purine-Pyrimidine Metabolism, Inborn Errors | 1 | 2022 | 3 | 0.720 |
Why?
|
| Metabolism, Inborn Errors | 5 | 2021 | 124 | 0.560 |
Why?
|
| Cytoskeletal Proteins | 6 | 2004 | 260 | 0.560 |
Why?
|
| Muscular Diseases | 4 | 2025 | 124 | 0.530 |
Why?
|
| Pyrimidines | 2 | 2022 | 451 | 0.510 |
Why?
|
| Blood Chemical Analysis | 1 | 2016 | 80 | 0.490 |
Why?
|
| Methionine | 1 | 2016 | 96 | 0.480 |
Why?
|
| Homocysteine | 1 | 2016 | 116 | 0.480 |
Why?
|
| Metabolomics | 6 | 2021 | 501 | 0.460 |
Why?
|
| Purines | 1 | 2016 | 113 | 0.450 |
Why?
|
| Glycine | 2 | 2022 | 156 | 0.450 |
Why?
|
| Phenylbutyrates | 4 | 2023 | 54 | 0.450 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 4 | 2020 | 112 | 0.400 |
Why?
|
| Bacterial Proteins | 6 | 2004 | 938 | 0.400 |
Why?
|
| Escherichia coli Proteins | 6 | 2004 | 316 | 0.380 |
Why?
|
| Neonatal Screening | 4 | 2022 | 201 | 0.380 |
Why?
|
| Biomarkers | 6 | 2022 | 3381 | 0.330 |
Why?
|
| Escherichia coli | 6 | 2004 | 989 | 0.330 |
Why?
|
| Urea Cycle Disorders, Inborn | 2 | 2023 | 84 | 0.320 |
Why?
|
| Metabolic Diseases | 1 | 2010 | 140 | 0.270 |
Why?
|
| Arginase | 2 | 2018 | 34 | 0.250 |
Why?
|
| Carnitine | 3 | 2015 | 70 | 0.250 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 2 | 2015 | 15 | 0.230 |
Why?
|
| Electron Transport | 1 | 2025 | 60 | 0.230 |
Why?
|
| Arginine | 4 | 2018 | 337 | 0.220 |
Why?
|
| Humans | 34 | 2025 | 130275 | 0.210 |
Why?
|
| Cell Nucleus | 2 | 2004 | 563 | 0.200 |
Why?
|
| Genetic Therapy | 3 | 2016 | 714 | 0.200 |
Why?
|
| Sequence Deletion | 1 | 2025 | 518 | 0.200 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2004 | 169 | 0.190 |
Why?
|
| Infant, Newborn | 6 | 2022 | 8517 | 0.190 |
Why?
|
| Child, Preschool | 13 | 2025 | 14934 | 0.190 |
Why?
|
| Nitric Oxide | 2 | 2018 | 465 | 0.190 |
Why?
|
| Argininosuccinic Aciduria | 2 | 2012 | 53 | 0.180 |
Why?
|
| Adenine Phosphoribosyltransferase | 1 | 2022 | 5 | 0.180 |
Why?
|
| Uracil | 1 | 2022 | 12 | 0.180 |
Why?
|
| Purine Nucleosides | 1 | 2022 | 11 | 0.180 |
Why?
|
| Thymine | 1 | 2022 | 13 | 0.180 |
Why?
|
| Thymidine | 1 | 2022 | 49 | 0.180 |
Why?
|
| Amidinotransferases | 2 | 2013 | 4 | 0.180 |
Why?
|
| Young Adult | 9 | 2025 | 9994 | 0.180 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2019 | 192 | 0.170 |
Why?
|
| Syndrome | 2 | 2022 | 1159 | 0.160 |
Why?
|
| Transaldolase | 1 | 2020 | 4 | 0.160 |
Why?
|
| Transketolase | 1 | 2020 | 17 | 0.160 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2020 | 15 | 0.160 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2020 | 39 | 0.160 |
Why?
|
| Infant | 8 | 2025 | 13223 | 0.160 |
Why?
|
| Cell Division | 5 | 2004 | 718 | 0.160 |
Why?
|
| Mitochondria | 1 | 2025 | 776 | 0.160 |
Why?
|
| Hartnup Disease | 1 | 2019 | 4 | 0.150 |
Why?
|
| Child | 14 | 2025 | 26072 | 0.150 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 2 | 2011 | 42 | 0.150 |
Why?
|
| Phenotype | 6 | 2020 | 4465 | 0.150 |
Why?
|
| Adolescent | 12 | 2025 | 20706 | 0.150 |
Why?
|
| Wolman Disease | 1 | 2019 | 7 | 0.150 |
Why?
|
| Sterol Esterase | 1 | 2019 | 20 | 0.150 |
Why?
|
| Glutaredoxins | 1 | 2019 | 31 | 0.140 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 1998 | 26 | 0.140 |
Why?
|
| Cognition | 1 | 2024 | 811 | 0.140 |
Why?
|
| Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 2018 | 5 | 0.140 |
Why?
|
| Cardiomegaly | 1 | 2019 | 118 | 0.140 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 170 | 0.140 |
Why?
|
| Hyperammonemia | 2 | 2015 | 59 | 0.140 |
Why?
|
| Chromosomes, Bacterial | 1 | 1998 | 64 | 0.140 |
Why?
|
| Leigh Disease | 1 | 2018 | 24 | 0.140 |
Why?
|
| Acyltransferases | 1 | 2018 | 62 | 0.140 |
Why?
|
| Genetic Association Studies | 2 | 2019 | 817 | 0.140 |
Why?
|
| Zellweger Syndrome | 1 | 2018 | 16 | 0.140 |
Why?
|
| Male | 21 | 2025 | 64362 | 0.140 |
Why?
|
| Peroxisomal Disorders | 1 | 2018 | 17 | 0.130 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2018 | 39 | 0.130 |
Why?
|
| Membrane Glycoproteins | 1 | 2019 | 409 | 0.130 |
Why?
|
| Liver | 4 | 2019 | 1788 | 0.130 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2018 | 144 | 0.130 |
Why?
|
| Tyrosinemias | 1 | 2016 | 7 | 0.120 |
Why?
|
| Limit of Detection | 1 | 2016 | 74 | 0.120 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 1998 | 212 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2019 | 767 | 0.120 |
Why?
|
| Spasms, Infantile | 1 | 2018 | 165 | 0.120 |
Why?
|
| Ankyrins | 1 | 2016 | 96 | 0.120 |
Why?
|
| Hyperargininemia | 1 | 2015 | 13 | 0.120 |
Why?
|
| Brain | 3 | 2024 | 3161 | 0.120 |
Why?
|
| Dopa Decarboxylase | 1 | 2015 | 7 | 0.110 |
Why?
|
| Urea | 2 | 2019 | 219 | 0.110 |
Why?
|
| Adult | 9 | 2025 | 31107 | 0.110 |
Why?
|
| Mass Screening | 1 | 2021 | 807 | 0.110 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2015 | 21 | 0.110 |
Why?
|
| Retrospective Studies | 6 | 2025 | 17507 | 0.110 |
Why?
|
| Statistics as Topic | 1 | 2016 | 240 | 0.110 |
Why?
|
| Exons | 4 | 2020 | 761 | 0.110 |
Why?
|
| Linear Models | 1 | 2016 | 686 | 0.110 |
Why?
|
| Citrullinemia | 1 | 2014 | 16 | 0.110 |
Why?
|
| Fasting | 1 | 2015 | 305 | 0.110 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2018 | 321 | 0.100 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2011 | 74 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 1278 | 0.100 |
Why?
|
| Gene Editing | 1 | 2016 | 234 | 0.100 |
Why?
|
| Bipolar Disorder | 1 | 2016 | 344 | 0.100 |
Why?
|
| Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2013 | 8 | 0.100 |
Why?
|
| Female | 15 | 2025 | 70278 | 0.100 |
Why?
|
| CRISPR-Cas Systems | 1 | 2016 | 317 | 0.100 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2013 | 24 | 0.100 |
Why?
|
| Speech Disorders | 1 | 2013 | 46 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2890 | 0.090 |
Why?
|
| Mice | 10 | 2020 | 18194 | 0.090 |
Why?
|
| Language Development Disorders | 1 | 2013 | 177 | 0.090 |
Why?
|
| Mental Disorders | 1 | 2019 | 899 | 0.090 |
Why?
|
| Aging | 1 | 2019 | 1243 | 0.090 |
Why?
|
| Autistic Disorder | 1 | 2015 | 395 | 0.090 |
Why?
|
| Genetic Testing | 1 | 2018 | 1099 | 0.080 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2010 | 14 | 0.080 |
Why?
|
| Nitrogen | 1 | 2011 | 120 | 0.080 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 4659 | 0.080 |
Why?
|
| Betaine | 1 | 2010 | 19 | 0.080 |
Why?
|
| Middle Aged | 4 | 2025 | 28352 | 0.080 |
Why?
|
| Movement Disorders | 1 | 2013 | 220 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 518 | 0.080 |
Why?
|
| Angelman Syndrome | 1 | 2010 | 67 | 0.080 |
Why?
|
| Glutamine | 1 | 2011 | 201 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 2822 | 0.080 |
Why?
|
| Prenatal Diagnosis | 1 | 2014 | 615 | 0.080 |
Why?
|
| Autism Spectrum Disorder | 1 | 2015 | 445 | 0.080 |
Why?
|
| Epilepsy | 1 | 2016 | 862 | 0.070 |
Why?
|
| Alleles | 3 | 2019 | 1677 | 0.070 |
Why?
|
| Ornithine Carbamoyltransferase | 1 | 2008 | 23 | 0.070 |
Why?
|
| Neurons | 1 | 2018 | 2001 | 0.070 |
Why?
|
| Folic Acid | 1 | 2010 | 269 | 0.070 |
Why?
|
| Animals | 10 | 2020 | 33777 | 0.070 |
Why?
|
| Mass Spectrometry | 2 | 2020 | 355 | 0.070 |
Why?
|
| Genotype | 3 | 2019 | 2590 | 0.070 |
Why?
|
| Time Factors | 1 | 2016 | 6194 | 0.060 |
Why?
|
| Intellectual Disability | 1 | 2013 | 1080 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2004 | 413 | 0.060 |
Why?
|
| Heart Failure | 1 | 2019 | 2328 | 0.060 |
Why?
|
| Proteins | 1 | 2011 | 1009 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2008 | 582 | 0.060 |
Why?
|
| Mutation | 6 | 2019 | 6084 | 0.050 |
Why?
|
| DNA, Circular | 1 | 2004 | 17 | 0.050 |
Why?
|
| Amino Acids | 2 | 2020 | 561 | 0.050 |
Why?
|
| Phenylacetates | 1 | 2023 | 26 | 0.050 |
Why?
|
| Acetates | 1 | 2023 | 78 | 0.050 |
Why?
|
| Phenols | 1 | 2023 | 72 | 0.050 |
Why?
|
| Protein Transport | 1 | 2004 | 366 | 0.050 |
Why?
|
| Cell Line | 2 | 2018 | 2561 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2024 | 307 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2004 | 572 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 590 | 0.040 |
Why?
|
| Fibroblasts | 2 | 2019 | 852 | 0.040 |
Why?
|
| Amino Acid Substitution | 2 | 2019 | 404 | 0.040 |
Why?
|
| Placebos | 2 | 2012 | 224 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2020 | 43 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2020 | 3822 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2001 | 118 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2018 | 1591 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 102 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2019 | 2897 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 1367 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2001 | 480 | 0.040 |
Why?
|
| Cell Cycle Proteins | 2 | 2001 | 712 | 0.040 |
Why?
|
| Phosphatidylethanolamines | 1 | 1998 | 22 | 0.040 |
Why?
|
| DNA Replication | 1 | 2001 | 361 | 0.040 |
Why?
|
| DNA Topoisomerase IV | 1 | 1998 | 10 | 0.040 |
Why?
|
| Thy-1 Antigens | 1 | 2018 | 18 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2018 | 28 | 0.040 |
Why?
|
| Muramoylpentapeptide Carboxypeptidase | 1 | 1998 | 5 | 0.030 |
Why?
|
| Chemistry, Organic | 1 | 2018 | 7 | 0.030 |
Why?
|
| Sphingomyelins | 1 | 2018 | 16 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 1998 | 69 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2018 | 90 | 0.030 |
Why?
|
| Rhizobiaceae | 1 | 1997 | 1 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2019 | 568 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2012 | 1622 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2018 | 185 | 0.030 |
Why?
|
| United States | 3 | 2019 | 11840 | 0.030 |
Why?
|
| Laboratories | 1 | 2018 | 79 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 242 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2018 | 5048 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2019 | 247 | 0.030 |
Why?
|
| Genetics, Medical | 1 | 2018 | 119 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 3396 | 0.030 |
Why?
|
| Nitrobenzoates | 1 | 2016 | 6 | 0.030 |
Why?
|
| Parvalbumins | 1 | 2016 | 35 | 0.030 |
Why?
|
| Cyclohexanones | 1 | 2016 | 18 | 0.030 |
Why?
|
| Hydrolases | 1 | 2016 | 61 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2016 | 263 | 0.030 |
Why?
|
| Carrier Proteins | 2 | 1998 | 999 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2016 | 105 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 523 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2016 | 419 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2015 | 82 | 0.030 |
Why?
|
| Genetic Carrier Screening | 1 | 2015 | 66 | 0.030 |
Why?
|
| Dihydroxyphenylalanine | 1 | 2015 | 9 | 0.030 |
Why?
|
| Interneurons | 1 | 2016 | 142 | 0.030 |
Why?
|
| Aged | 3 | 2021 | 20857 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2016 | 235 | 0.030 |
Why?
|
| Tyrosine | 1 | 2015 | 143 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 310 | 0.030 |
Why?
|
| Argininosuccinate Synthase | 1 | 2014 | 25 | 0.030 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2015 | 82 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 796 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 1022 | 0.030 |
Why?
|
| Hypoglycemia | 1 | 2015 | 183 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 4711 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 670 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 559 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2018 | 846 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 1694 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 2014 | 146 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2014 | 577 | 0.020 |
Why?
|
| Argininosuccinic Acid | 1 | 2012 | 7 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 1949 | 0.020 |
Why?
|
| Citrulline | 1 | 2014 | 123 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 1873 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2012 | 96 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2012 | 80 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 995 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2015 | 671 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3790 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2012 | 154 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 1319 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2013 | 177 | 0.020 |
Why?
|
| Argininosuccinate Lyase | 1 | 2012 | 62 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2015 | 449 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 322 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 2330 | 0.020 |
Why?
|
| Creatinine | 1 | 2013 | 396 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 731 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1486 | 0.020 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2010 | 10 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 725 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2015 | 922 | 0.020 |
Why?
|
| Keto Acids | 1 | 2010 | 50 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2010 | 84 | 0.020 |
Why?
|
| Lipotropic Agents | 1 | 2010 | 5 | 0.020 |
Why?
|
| Fetus | 1 | 2014 | 566 | 0.020 |
Why?
|
| Vitamin B Complex | 1 | 2010 | 36 | 0.020 |
Why?
|
| Seizures | 1 | 2015 | 874 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2090 | 0.020 |
Why?
|
| Genomics | 1 | 2018 | 1612 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2013 | 1059 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2010 | 143 | 0.020 |
Why?
|
| Genomic Imprinting | 1 | 2010 | 123 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2010 | 271 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 1822 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 2460 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 1166 | 0.020 |
Why?
|
| Orotic Acid | 1 | 2008 | 14 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2008 | 85 | 0.020 |
Why?
|
| Helper Viruses | 1 | 2008 | 45 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 355 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 6792 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2013 | 775 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 359 | 0.020 |
Why?
|
| Luminescent Proteins | 2 | 1998 | 144 | 0.020 |
Why?
|
| Transgenes | 1 | 2008 | 320 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2010 | 1575 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 2 | 1998 | 365 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 3744 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1998 | 693 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2008 | 895 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2010 | 1073 | 0.010 |
Why?
|
| Hypertension | 1 | 2012 | 1347 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 7412 | 0.010 |
Why?
|
| Peptidyl Transferases | 1 | 1998 | 5 | 0.010 |
Why?
|
| Hexosyltransferases | 1 | 1998 | 8 | 0.010 |
Why?
|
| Penicillin-Binding Proteins | 1 | 1998 | 14 | 0.010 |
Why?
|
| Agrobacterium tumefaciens | 1 | 1997 | 3 | 0.010 |
Why?
|
| Sinorhizobium meliloti | 1 | 1997 | 2 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 1998 | 76 | 0.010 |
Why?
|
| Species Specificity | 1 | 1997 | 474 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1997 | 623 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 780 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1997 | 2400 | 0.010 |
Why?
|
| Base Sequence | 1 | 1997 | 2737 | 0.010 |
Why?
|
| Gene Expression | 1 | 1998 | 1486 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1997 | 3473 | 0.010 |
Why?
|